BRISKPE, a Prosus-backed cross-border payments platform, has reached a major milestone by securing the Reserve Bank of ...

The trial’s first phase will begin in university hospitals across the Netherlands, Denmark, Germany and Sweden.

Anocca has achieved regulatory approval for its first clinical trial, VIDAR-1, a major milestone in the company’s transition ...

The Supreme Court on Wednesday held advocates did not have an “indefeasible right” to appear and get their appearances marked in judicial records without the authorisation to represent litigants. The ...

The strategic acquisition enhances Infinx's patient access solutions and expands its presence in the laboratory market, where ...

The CTA approval is the first regulatory authorisation in Europe to study a non-viral gene-edited TCR-T therapy in clinical practice, paving the way for the execution of Anocca’s scalable ...